Wearable data-analytics startup VivoSense scored $25 million in a Series A funding round co-led by Perceptive Xontogeny Ventures (PXV) Fund and Debiopharm Innovation Fund.
The Newport Beach, Calif.-based company helps stakeholders integrate wearable sensors into clinical trials to help monitor digital biomarkers. The company has software called VivoSense, which helps interpret sensor data for...
Digital therapeutic Click Therapeutics has tapped AI-backed neurological disease diagnostic Altoida in to help it incorporate more sensitive measures of cognition into their DTx research.
The partnership will bring Altoida's cognition measuring capabilities into Click's clinical trials.
“Partnering with Altoida allows us to leverage their AI-driven augmented reality technology to help us better...
This morning Altoida, a digital platform that uses artificial intelligence and machine learning to help predict Alzheimer’s disease, closed a $6.3 million Series A funding round. M Ventures led the round with participation from Grey Sky Venture Partners, VI Partners AGG, Alpana Ventures and FYRFLY Ventures.
WHAT THEY DO
Altoida makes a digital platform that employs AI, ML and augmented reality...
